A study to investigate the effect of ASP1517 after intermittent oral dosing in dialysis chronic kidney disease patients with anemia compared with darbepoetin as a reference drug

Trial Identifier: 1517-CL-0304
Sponsor: Astellas Pharma Inc.
NCTID:: NCT01888445
Start Date: March 2013
Primary Completion Date: September 2014
Condition: Chronic Kidney Diseases

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

Country Location
Japan Chubu, Japan
Japan Chugoku, Japan
Japan Hokuriku, Japan
Japan Kansai, Japan
Japan Kanto, Japan
Japan Kyushu, Japan
Japan Shikoku, Japan
Japan Tohoku, Japan